Petunia-calibrachoa variety SAKPXC023
AssigneeSakata Seed Corporation
InventorJun Tsukahara
Life of this patent
Estimating the term…
Loading patent…
AssigneeSakata Seed Corporation
InventorJun Tsukahara
Estimating the term…
A petunia-calibrachoa plant designated SAKPXC023 is disclosed. Embodiments include the seeds of petunia-calibrachoa SAKPXC023, the plants of petunia-calibrachoa SAKPXC023, to plant parts of petunia-calibrachoa SAKPXC023, and methods for producing a plant produced by crossing petunia-calibrachoa SAKPXC023 with itself or with another variety. Embodiments include methods for producing a plant containing in its genetic material one or more genes or transgenes and the transgenic plants and plant parts produced by those methods. Embodiments also relate to varieties, breeding varieties, plant parts, and cells derived from petunia-calibrachoa SAKPXC023, methods for producing other lines or plant parts derived from petunia-calibrachoa SAKPXC023, and the plants, varieties, and their parts derived from use of those methods. Embodiments further include hybrid seeds, plants, and plant parts produced by crossing petunia-calibrachoa SAKPXC023 with another variety.
A plant of petunia-calibrachoa variety SAKPXC023, wherein a representative sample of plant tissue of SAKPXC023 was deposited under NCMA No. 201907002.
A method of introducing a mutation into the genome of petunia-calibrachoa plant SAKPXC023 said method comprising mutagenesis of the plant, or plant part thereof, wherein said mutagenesis is selected from the group consisting of temperature, long-term seed storage, tissue culture conditions, ionizing radiation, chemical mutagens, or targeting induced local lesions in genomes, and wherein the resulting plant comprises at least one genome mutation.
A method of editing the genome of petunia-calibrachoa plant SAKPXC023, said method comprising editing the genome of the plant, or plant part thereof, wherein a representative sample of plant tissue of SAKPXC023 was deposited under NCMA No. 201907002, wherein said method is selected from the group comprising zinc finger nucleases, transcription activator-like effector nucleases (TALENs), engineered homing endonucleases/meganucleases, and the clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein9 (Cas9) system.
Dependencies are inferred from the claim text.